Fitness Supplement Company Accounting: From Production to Profit

April 6, 2026

By: Paul Lembo

Partner, Assurance

Key Takeaways

COGS in supplement manufacturing are more complex than they look. Ingredient costs, encapsulation or blending fees, certificate of analysis (COA) testing, and contract manufacturing minimums all belong in cost of goods sold — and miscategorizing any of them distorts gross margin from the ground up.
The FDA’s Current Good Manufacturing Practice (cGMP) regulations create accounting expenses that must be classified correctly — quality system maintenance, third-party audits, and lab testing are operating expenses unless they are directly attributable to a specific production run.
Inventory valuation for supplement companies requires active management of expiration dates. Product approaching its “best by” date that cannot be sold at full price must be written down to net realizable value in the period the impairment becomes known, not the period the product expires.
DTC and wholesale channels have materially different revenue recognition requirements under ASC 606, and mixing the two in a single revenue line without proper segregation results in unreliable channel-by-channel gross margin analysis.
R&D tax credits under IRC Section 41 are often available to supplement manufacturers developing new formulations and are frequently unclaimed because founders assume the credit applies onlyto pharmaceutical or technology companies.
Bottom line: Supplement manufacturing sits at the intersection of food production, regulated products, and consumer brands. The accounting has to account for all three.

The fitness supplement industry has a particular profile that creates accounting complexity that most general-purpose CPAs underestimate. The business looks, on the surface, like a straightforward product company: buy ingredients, manufacture product, sell to consumers or retailers. In practice, the cost structure involves multiple contract parties, regulatory compliance costs, intellectual property development, channel-specific margin dynamics, and inventory with a fixed biological clock.

Getting the financials right is not just about compliance. It is about understanding where the margin actually lives — and where it is quietly disappearing.

Cost of Goods Sold: What the Number Should Actually Include

For supplement manufacturers — whether manufacturing in-house or through a contract manufacturer (co-man) — the correct COGS composition is the foundation of all other financial analyses. A gross margin figure built on an incomplete or improperly classified COGS number is not just inaccurate; it actively misleads pricing decisions, channel profitability analysis, and enterprise valuation.

COGS for a fitness supplement company properly includes the following:

Raw materials and active ingredients. The cost of every bulk ingredient that goes into the finished product, including active compounds, excipients, fillers, and flow agents. For companies purchasing under long-term supply agreements, the cost basis is the contracted price plus any inbound freight and import duties. Spot purchases need to be tracked separately to the extent they represent a cost deviation from the standard.

Contract manufacturing fees. When production is outsourced to a co-man, the blending, encapsulation, tableting, or filling fees paid per unit or per production run are direct COGS. Minimum order charges are also COGS — they represent the cost of accessing production capacity — and should not be deferred or expensed as period costs simply because a run produced more units than were immediately needed.

Packaging and labeling costs. Primary packaging (bottles, pouches, blister packs) and secondary packaging (boxes, shrink wrap) are direct COGS. Label printing is direct COGS. Packaging design is not.

Certificate of analysis and third-party testing costs. COA testing of raw ingredients and finished goods is directly attributable to production and is included in COGS. This is one of the most consistently misclassified costs in supplement accounting — it routinely ends up in operating expenses because it appears on a lab invoice rather than a co-man invoice. The classification should follow the economic substance of the cost, not the invoice format.

Inbound freight on materials. Shipping costs to receive ingredients and packaging at the point of production are COGS. Outbound freight to customers is not; it belongs in operating expenses as fulfillment or shipping costs.

What does not belong in COGS: formulation development costs for new products, regulatory compliance consulting, FDA facility registration fees, and marketing-related samples. These are period operating expenses.

Inventory Valuation: The Expiration Date Problem

Supplement inventory has a mandatory shelf life, typically printed as a “best by” or “expiration” date required under FDA labeling regulations. That date is not just a regulatory requirement — it is a financial event horizon.

Under U.S. GAAP, inventory must be stated at the lower of cost or net realizable value. Net realizable value (NRV) is the estimated selling price in the ordinary course of business, less estimated costs of completion, disposal, and transportation. When a product is approaching expiration and cannot be sold at full price — whether through normal channels, liquidation, or sale at discount — the carrying value must be written down to NRV in the period the impairment becomes probable, not the period the product actually expires.

In practice, this means supplement companies should maintain an active expiration date report by lot and SKU, reviewed at a minimum quarterly, that flags inventory with remaining shelf life insufficient for normal distribution. Retailers typically require a minimum remaining shelf life — often 6 months to 1 year from receipt — before accepting the product. Inventory that falls below that window is effectively stranded even if it has not technically expired.

Recognizing these write-downs only during the annual physical inventory count is one of the most common sources of overstated inventory on supplement company balance sheets. It is also one of the first things a sophisticated acquirer or lender will scrutinize.

Revenue Recognition: DTC vs. Wholesale vs. Amazon

Supplement companies commonly sell through three distinct channels: direct-to-consumer (website, subscription programs), wholesale (gyms, specialty retail, national chains), and third-party marketplace (Amazon). Each has a different revenue recognition profile under ASC 606.

DTC and subscription. Revenue from a single direct purchase is straightforward — recognized when control of the product transfers to the customer, typically at shipment for FOB shipping point arrangements. Subscription programs, however, require that each delivery obligation be identified as a separate performance obligation and that revenue be recognized as each delivery is fulfilled. Collecting subscription fees in advance and booking them immediately as revenue is incorrect; the unearned portion is a contract liability on the balance sheet.

Wholesale. Revenue from wholesale customers is recognized at the point of transfer of control, adjusted for variable consideration — principally, estimated returns and any promotional allowances agreed under the customer contract. These amounts must be estimated and deducted from gross revenue at the time of sale, establishing a refund liability on the balance sheet. Waiting until returns actually occur to recognize them understates the refund liability and overstates net revenue.

Amazon and third-party marketplaces. The revenue recognition question here is whether the supplement company is acting as a principal or an agent. For sellers using Fulfilled by Amazon (FBA), the company is typically the principal, recognizing gross revenue when Amazon records the sale, with Amazon’s fees (referral fees, fulfillment fees) classified as selling expenses. Netting these fees against revenue — a common shortcut — understates both gross revenue and operating expenses, which matters for any analysis that benchmarks gross margin or operating expense ratios against industry comparables.

R&D Tax Credits: The Credit Most Supplement Companies Don’t Know They Qualify For

Under IRC Section 41, the research and development tax credit is available to companies incurring qualified research expenses — defined as amounts paid to develop or improve a product or process through experimentation. Many supplement companies engage in qualifying activities but do not claim the credit because they assume it applies only to pharmaceutical or technology businesses.

In supplement manufacturing, the following activities may qualify for R&D tax credit treatment: developing and testing new formulations; conducting stability testing to determine shelf life for new products; developing new delivery mechanisms (capsules, powders, ready-to-drink); and improving manufacturing processes to address quality or consistency issues.

The credit is calculated as a percentage of qualified research expenses above a base amount, and it provides a dollar-for-dollar reduction in federal income tax liability. For small businesses meeting the definition under IRC Section 41(h), the credit can be applied against payroll taxes rather than income taxes — making it accessible even to pre-profit companies.

The qualification analysis requires documentation of the research activities, the personnel involved, and the amounts incurred. It is not self-executing — it requires a structured study — but for supplement companies actively developing new products, the credit is routinely worth the effort.

Accounting for Your Supplement Business

Supplement accounting sits at the junction of manufacturing, regulated products, consumer brands, and multi-channel retail. Each of those domains brings its own accounting requirements, and the companies that handle them well build financial statements that tell a clear, accurate story — to their lenders, their investors, and eventually their acquirers.

The companies that handle them poorly end up with a gross margin they can’t defend, an inventory balance they can’t explain, and tax credits they left on the table.

The Wiss CPG advisory team works with supplement manufacturers and consumer health brands on financial operations, tax strategy, and the accounting structure that supports sustainable growth. If your financials aren’t keeping pace with your production, reach out.